Active, Not Recruiting
Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer
NCT01480154
- Conditions
- Adenocarcinoma, Advanced Malignant Solid Neoplasm, Carcinoma, +37 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States